The risk SNP rs6931104 lowers the binding affinity of TF RFX3; it also reduces the expression of RMND1. These results suggest that a reduction in the expression levels of RMND1, which serves as a tumor suppressor gene, is associated with CML pathogenesis. This evidence concerns the gene RFX3 and chronic myelogenous leukemia, BCR-ABL1 positive.